8,751 results match your criteria Catheterization and Cardiovascular Interventions[Journal]


Sex differences in the treatment and outcomes of patients hospitalized with ST-elevation myocardial infarction.

Catheter Cardiovasc Interv 2019 Apr 22. Epub 2019 Apr 22.

Department of Cardiology, St. Joseph's Health System, Atlanta, Georgia.

Objectives: To compare mortality for women and men hospitalized with ST-elevation myocardial infarction (STEMI) by age and revascularization status.

Background: There is little information on the mortality of men and women not undergoing revascularization, and the impact of age on relative male-female mortality needs to be revisited.

Methods And Results: An observational database of 23,809 patients with STEMI presenting at nonfederal New York State hospitals between 2013 and 2015 was used to compare risk-adjusted inhospital/30-day mortality for women and men and to explore the impact of age on those differences. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28286
Publisher Site
http://dx.doi.org/10.1002/ccd.28286DOI Listing
April 2019
1 Read

Three to four years outcomes of the absorb bioresorbable vascular scaffold versus second-generation drug-eluting stent: A meta-analysis.

Catheter Cardiovasc Interv 2019 Apr 19. Epub 2019 Apr 19.

Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York.

Objective: This meta-analysis sought to evaluate the outcomes of absorb bioresorbable vascular scaffolds (BVS) compared with second-generation drug-eluting stents (DES) after 3 years, the approximate time of complete polymer bioresorption.

Background: BVS were found to be inferior to second-generation DES in early and mid-term outcomes with a higher rate of target vessel myocardial infarction (TV-MI) and device thrombosis (DT). Improper implantation techniques and incomplete bioresorption of the poly-l-lactide (PLLA) polymer were sighted as possible reasons. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28290
Publisher Site
http://dx.doi.org/10.1002/ccd.28290DOI Listing
April 2019
1 Read

Emergency treatment of iatrogenic coronary perforation by transcatheter embolization with gelatin sponge particles-Description of technique.

Catheter Cardiovasc Interv 2019 Apr 19. Epub 2019 Apr 19.

Department of Cardiology, Poznań University of Medical Sciences, Poznan, Poland.

Coronary artery perforation (CAP) is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI) that requires prompt diagnosis and effective treatment. Importantly, dynamic advances in interventional cardiology reflected by the increasing percentage of more challenging PCIs performed in more complex lesions have resulted in significant changes in CAPs pattern. Herein, we describe a technique and present a case report of CAP that occurred during percutaneous recanalization of the occluded restenotic right coronary artery (RCA) successfully treated with transcatheter embolization using gelatin sponge particles prepared on-site. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28291
Publisher Site
http://dx.doi.org/10.1002/ccd.28291DOI Listing
April 2019
1 Read

Iatrogenic atrial septal defect closure after transseptal mitral valve interventions: Indications and outcomes.

Catheter Cardiovasc Interv 2019 Apr 19. Epub 2019 Apr 19.

Division of Cardiovascular Medicine, UC Davis Medical Center, Sacramento, California.

Objectives: Review indications and outcomes for transcatheter iatrogenic atrial septal defect (iASD) closure in patients undergoing MitraClip or transseptal (TS) mitral valve-in-valve/ring (ViV/ViR) procedures.

Background: Mitral valve transcatheter interventions require large-diameter TS sheaths that can result in iASDs that necessitate post-procedure transcatheter closure. Although the presence of iASD has been well-described, indications for closure and outcomes after TS mitral valve interventions have not been reported. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28294DOI Listing

Slender distal radial five French coronary shockwave lithotripsy.

Catheter Cardiovasc Interv 2019 Apr 19. Epub 2019 Apr 19.

Division of Cardiology, Sant'Eugenio Hospital, Rome, Italy.

Despite technological evolution, percutaneous coronary interventions targeting coronary calcifications remain challenging and associated with high rates of complications and adverse outcomes. Over the years, rotational atherectomy has emerged as the reference treatment of calcified coronary artery lesions despite some inherent limitations. Also, rotational atherectomy typically requires relatively large guiding catheters which may unfavorably impact on the decision for transradial access, especially when radial artery is small, and consequently offset the relevant clinical benefits associated to transradial access. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28296
Publisher Site
http://dx.doi.org/10.1002/ccd.28296DOI Listing
April 2019
1 Read

First use and limitations of Magmaris® bioresorbable stenting in a low birth weight infant with native aortic coarctation.

Catheter Cardiovasc Interv 2019 Apr 19. Epub 2019 Apr 19.

Department of Pediatric Cardiology, Charité - Universitätsmedizin Berlin, Berlin, Germany.

We, herein, report the first use of a Magmaris® magnesium-based vascular scaffold for native aortic coarctation in a 1,980 g infant with multiple malformations. Due to the low body weight, complex illness, and clinical instability, it was decided to delay surgical correction. After insufficient results had been obtained by balloon angioplasty, Magmaris® implantation was chosen to bridge the patient to surgery by stabilizing left ventricular function and to allow for sufficient growth. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28300DOI Listing

Conversations in cardiology-When to tell an interventionalist to retire.

Authors:
Morton J Kern

Catheter Cardiovasc Interv 2019 Apr 16. Epub 2019 Apr 16.

Department of Medicine, Veterans Administration Long Beach Health Care System, Long Beach, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28273DOI Listing

Two-year safety evaluation of a biodegradable polymer sirolimus-eluting stent with increased drug elution and polymer absorption kinetics in complex patient and lesion cohort.

Catheter Cardiovasc Interv 2019 Apr 16. Epub 2019 Apr 16.

Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences, Beijing, China.

Objectives: The aim of the present report was to compare 2-year safety outcomes of two biodegradable polymer (BP) sirolimus-eluting stents (SESs) with different drug eluting and polymer absorption kinetics in a subgroup of complex patients and lesions.

Background: The previously published PANDA III study showed the BuMA BP SES, with faster drug elution and polymer absorption, was non-inferior to the Excel SES in target lesion failure (TLF).

Methods: In PANDA III trial, patients who fulfilled one or more of the following criteria were included: Small vessel disease (reference vessel diameter ≤ 2. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28288
Publisher Site
http://dx.doi.org/10.1002/ccd.28288DOI Listing
April 2019
2 Reads

Adverse events and modes of failure related to the FilterWire EZ Embolic Protection System: Lessons learned from an analytic review of the FDA MAUDE database.

Catheter Cardiovasc Interv 2019 Apr 15. Epub 2019 Apr 15.

Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, District of Columbia.

Objectives: To assess the commonly reported complications and failure modes for FilterWire EZ Embolic Protection Devices (EPD) by analyzing the postmarketing surveillance data from the Food and Drug Administration (FDA) Manufacturer and User Facility Device Experience (MAUDE) database.

Background: EPDs prevent distal embolization of atheroembolic materials during percutaneous interventions resulting in reduced microvascular obstruction and improved microcirculation while maintaining tissue perfusion. The FilterWire EZ EPD (Boston Scientific, Natick, MA) is approved for use in interventions of de novo saphenous vein grafts (SVG) and carotid artery stenosis. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28297DOI Listing
April 2019
1 Read

Impact of low-dose prasugrel on platelet reactivity and cardiac dysfunction in acute coronary syndrome patients requiring primary drug-eluting stent implantation: A randomized comparative study.

Catheter Cardiovasc Interv 2019 Apr 14. Epub 2019 Apr 14.

Division of Cardiology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.

Objective: The aim of this study was to compare how prasugrel and clopidogrel affect platelet aggregation reactivity, cardiac enzyme release, cardiac remodeling, and the formation of in-stent thrombi after primary percutaneous coronary intervention (PCI).

Background: The advantages of using prasugrel over clopidogrel in cardiac injury following acute coronary syndrome (ACS) remain unclear.

Methods: A total of 78 ACS patients were randomly allocated into clopidogrel (300 mg loading/75 mg maintenance) or prasugrel (20 mg loading/3. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28277DOI Listing
April 2019
1 Read

Hybrid approach to ventricular septal defect enlargement.

Catheter Cardiovasc Interv 2019 Apr 14. Epub 2019 Apr 14.

Division of Cardiology, Department of Pediatrics, UC Davis Children's Hospital, Sacramento, California.

The need for creation or enlargement of a ventricular septal defect (VSD) is a rare occurrence. It is most frequently required in patients with double-outlet right ventricle who develop restriction of a remote muscular VSD or obstruction of a perimembranous VSD secondary to atrioventricular (AV) valve attachments to the interventricular septum. Surgical and transcatheter options for VSD creation or enlargement are associated with several risks including heart block, AV valve injury, and perforation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28227DOI Listing
April 2019
1 Read

Strategies for radiation exposure-sparing in fluoroscopically guided invasive cardiovascular procedures.

Catheter Cardiovasc Interv 2019 Apr 13. Epub 2019 Apr 13.

Cardiovascular Medicine Division, Hospital of the University of Pennsylvania, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Background: Minimizing radiation exposure during x-ray fluoroscopically guided procedures is critical to patients and to medical personnel. Tableside adjustment of x-ray image acquisition parameters can vary the fluoroscopic radiation exposure rate.

Objectives: To determine the impact of adjusting four tableside controllable image acquisition parameters on x-ray fluoroscopic radiation exposure rate. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28281DOI Listing

Impact of strut thickness and number of crown and connectors on clinical outcomes on patients treated with second-generation drug eluting stent.

Catheter Cardiovasc Interv 2019 Apr 13. Epub 2019 Apr 13.

Division of Cardiology, Città Della Salute e della Scienza Hospital, Turin, Italy.

Introduction: In new generation drug eluting stents (DESs) era, the impact of stent geometry on freedom from recurrent events has been poorly explored. Impact of struts thickness and the number of crowns and connectors on clinical outcomes were evaluated in the present study.

Methods: Randomized controlled trials comparing last generation DESs were selected. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28228DOI Listing

Effect of cutting balloon after rotational atherectomy in severely calcified coronary artery lesions as assessed by optical coherence tomography.

Catheter Cardiovasc Interv 2019 Apr 11. Epub 2019 Apr 11.

Division of Cardiology, Showa University Northern Yokohama Hospital, Yokohama, Japan.

Objectives: Using optical coherence tomography (OCT), we evaluated the effect of a cutting balloon (CB) compared with a conventional balloon after rotational atherectomy (RA) and before stenting in severely calcified coronary lesions.

Background: A CB is designed to create discrete incisions to facilitate fracture of severely calcified plaque.

Methods: OCT was performed preintervention (if possible), post-RA, and poststent implantation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28278DOI Listing

Association between debulking area of rotational atherectomy and platform revolution speed-Frequency domain optical coherence tomography analysis.

Catheter Cardiovasc Interv 2019 Apr 11. Epub 2019 Apr 11.

Department of Cardiovascular Medicine, Osaka City University Graduate School of Medicine, Osaka, Japan.

Objectives: In this study, we sought to investigate the association between revolution speed of rotational atherectomy (RA) and debulking area assessed by frequency domain-optical coherence tomography (FD-OCT).

Background: The number of patients with severe calcified coronary artery disease requiring treatment with calcium ablation, such as RA, is increasing. However, there is little evidence available regarding the association between debulking area and revolution speed during RA. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28212DOI Listing

Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.

Catheter Cardiovasc Interv 2019 Apr 11. Epub 2019 Apr 11.

Department of Cardiology, Keio University School of Medicine, Tokyo, Japan.

Objectives: This study aimed to compare the clinical impact of mild postprocedural aortic regurgitation (post-AR) to that of none-trivial post-AR after transcatheter aortic valve implantation (TAVI) and to identify the vulnerability factors to mild post-AR.

Background: Moderate-severe post-AR, associated with increased mortality, is an important issue. However, the clinical impact of mild post-AR remains controversial. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28279DOI Listing
April 2019
1 Read

Mixed aortic valve disease treated with transcatheter aortic valve replacement in a high risk patient presenting with acute decompensated heart failure.

Catheter Cardiovasc Interv 2019 Apr 10. Epub 2019 Apr 10.

Division of Cardiovascular Medicine, University of Southern California, Los Angeles, California.

Mixed aortic valve disease refers to the combination of aortic regurgitation (AR) and aortic stenosis (AS). Commonly etiologies include a bicuspid aortic valve, rheumatic heart disease, and endocarditis superimposed upon a stenotic aortic valve. Treatment depends upon the severity of disease, the presence of symptoms and the size and function of the left ventricle. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28221DOI Listing
April 2019
1 Read

Clinical outcomes at 2 years of the Absorb bioresorbable vascular scaffold versus the Xience drug-eluting metallic stent in patients presenting with acute coronary syndrome versus stable coronary disease-AIDA trial substudy.

Catheter Cardiovasc Interv 2019 Apr 9. Epub 2019 Apr 9.

Amsterdam UMC, University of Amsterdam, Heart Center, Academic Medical Center, Amsterdam, The Netherlands.

Background: Patients with acute coronary syndrome (ACS) might represent a specific subgroup, in which bioresorbable scaffold implantation in percutaneous coronary intervention (PCI), might lead to better outcomes when compared to conventional treatment with metallic drug eluting stents. In this prespecified subgroup analysis of the Amsterdam Investigator-Initiated Absorb Strategy All-Comers (AIDA) trial, we evaluated the clinical outcomes of Absorb bioresorbable vascular scaffold (BVS) versus Xience everolimus eluting stent (EES) treated patients presenting either with or without ACS.

Methods And Results: We classified AIDA patients on the basis of clinical presentation of ACS or of no-ACS. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28193DOI Listing
April 2019
1 Read
2.107 Impact Factor

Exercise testing after chronic total coronary occlusion revascularization in patients with STEMI and a concurrent CTO: A subanalysis of the EXPLORE-trial.

Catheter Cardiovasc Interv 2019 Apr 9. Epub 2019 Apr 9.

Department of Cardiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, University of Amsterdam, Heart Center, The Netherlands.

Objectives: To assess the effect of chronic total occlusion percutaneous coronary intervention (CTO PCI) on ventricular ectopy (VE) and symptomatology during exercise testing.

Background: During exercise, the hypoxic myocardium in the CTO-territory can act as a substrate for VE and could lead to anginal complaints.

Methods: In the EXPLORE-trial, 302 ST-segment elevation myocardial infarction (STEMI)-patients were randomized to CTO PCI or no-CTO PCI. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28282
Publisher Site
http://dx.doi.org/10.1002/ccd.28282DOI Listing
April 2019
2 Reads

Direct access valve-in-valve implantation for management of complex valvulopathy.

Catheter Cardiovasc Interv 2019 Apr 8. Epub 2019 Apr 8.

Division of Cardiothoracic Surgery, New York Presbyterian Hospital-Columbia University Medical Center, New York, New York.

The management of bioprosthetic structural valve degeneration requires complex surgical or transcatheter re-intervention for which many high-risk patients are not considered candidates. Here, we describe a technique for a direct surgical access valve-in-valve implantation in patients with complex bioprosthetic valvulopathy for whom standard surgical valve replacement and percutaneous interventions were high-risk and contraindicated, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28179DOI Listing

In-hospital gastrointestinal bleeding following percutaneous coronary intervention.

Catheter Cardiovasc Interv 2019 Apr 8. Epub 2019 Apr 8.

Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, UK.

Objectives: This study aims to examine in-hospital gastrointestinal (GI) bleeding, its predictors and clinical outcomes, including long-term outcomes, in a national cohort of patients undergoing percutaneous coronary intervention (PCI) in England and Wales.

Background: GI bleeding remains associated with significant morbidity, mortality, and socioeconomic burden.

Methods: We examined the temporal changes in in-hospital GI bleeding in a national cohort of patients undergoing PCI between 2007 and 2014 in England and Wales, its predictors and prognostic consequences. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/ccd.28222
Publisher Site
http://dx.doi.org/10.1002/ccd.28222DOI Listing
April 2019
6 Reads

Diagnostic performance of quantitative flow ratio in prospectively enrolled patients: An individual patient-data meta-analysis.

Catheter Cardiovasc Interv 2019 Apr 9. Epub 2019 Apr 9.

Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.

Objectives: We aimed to provide robust performance estimates for quantitative flow ratio (QFR) in assessment of intermediary coronary lesions.

Background: Angiography-based functional lesion assessment by QFR may appear as a cost saving and safe approach to expand the use of physiology-guided percutaneous coronary interventions. QFR was proven feasible and showed good diagnostic performance in mid-sized off-line and on-line studies with fractional flow reserve (FFR) as reference standard. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28283DOI Listing

Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease: A single center experience.

Catheter Cardiovasc Interv 2019 Apr 7. Epub 2019 Apr 7.

Department of Cardiology, Norfolk and Norwich University Hospital, Norwich, UK.

Objective: To report our initial experience with drug coated balloon (DCB) only angioplasty and propose a protocol to achieve this safely.

Background: There are no articles published in the literature currently regarding the safety of same day discharge in patients treated with DCB-only angioplasty.

Methods: Retrospective review of all our patients treated with DCB-only angioplasty from September 2017 to April 2018 with identification of potential complications relating to same day discharge. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28217DOI Listing
April 2019
5 Reads

Clinical utility of surveillance and clinically prompted right heart catheterization in patients listed for heart transplantation.

Catheter Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Cardiovascular Division, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

Background And Objectives: The 2016 ISHLT guidelines recommend that patients listed for orthotopic heart transplantation (OHT) undergo periodic surveillance right heart catheterization (RHC) to re-assess hemodynamics (Class I, level of evidence C). However, the impact of RHC on management remains unclear. The aim of this study was to determine the utility of both surveillance and clinically prompted RHCs in patients listed for OHT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28272DOI Listing
April 2019
4 Reads
2.107 Impact Factor

Left ventricular end-diastolic pressure in acute myocardial infarction: A loaded target in need of unloading.

Catheter Cardiovasc Interv 2019 Apr;93(5):910-911

Henry Ford Medical Center, Detroit, Michigan.

Left ventricular (LV) end-diastolic pressure predicts short- and long-term mortality and correlates with infarct size after ST-segment elevation acute myocardial infarction. Ventricular load refers to any variable that increases myocardial oxygen consumption including LV pressure, volume, or heart rate. Clinical studies of ventricular "unloading" as a therapeutic approach for acute myocardial infarction with and without cardiogenic shock are ongoing. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28204DOI Listing
April 2019
2 Reads

Hey, American College of Cardiology interventionalists: What are you thinking?

Authors:
Samuel M Butman

Catheter Cardiovasc Interv 2019 Apr;93(5):880-881

Cardiovascular Research, Verde Valley Medical Center, Cottonwood, Arizona.

There is large variation in the utilization of the appropriate Use-Criteria (AUC). There has been a significant decrease in the number of Percutaneous coronary intervention (PCI) cases deemed rarely appropriate. The value of the AUC remains a questionable tool for many clinicians. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28200DOI Listing
April 2019
1 Read

Advances in the treatment of coronary perforations.

Catheter Cardiovasc Interv 2019 Apr;93(5):921-922

Minneapolis Heart Institute and Minneapolis Heart Institute Foundation, Abbott Northwestern Hospital, Minneapolis, Minnesota.

Coronary artery perforation is an infrequent, but potentially life-threatening complication of percutaneous coronary intervention. There are four types of coronary perforation: (a) large vessel; (b) distal vessel; (c) septal collateral; and (d) epicardial collateral perforation. Implantation of a covered stent is the cornerstone of large vessel perforation treatment and can be used in some distal vessel perforations, when embolization is not feasible. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28205DOI Listing
April 2019
3 Reads

A match not made in heaven-TAVR prosthesis-patient mismatch with contemporary valves.

Catheter Cardiovasc Interv 2019 Apr;93(5):980-981

Center for Structural and Congenital Heart Disease, Heart and Vascular Hospital, Hackensack, University Medical Center and Seton Hall Hackensack Meridian School of Medicine, Hackensack, NJ.

Prosthesis-patient mismatch (PPM) in TAVR is relatively common Valve oversizing can potentially prevent both paravalvular leak and PPM PPM may be avoidable if the expected Effective Orifice Area/Body Surface Area ratio is considered in decision making pre-TAVR. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28201DOI Listing
April 2019
1 Read

A hot lead on reducing infarct size.

Catheter Cardiovasc Interv 2019 Apr;93(5):891-892

Department of Cardiology 27-75, Geisinger Medical Center, Danville, Pennsylvania.

The intracoronary hyperoxemic oxygen therapy study, designed to demonstrate the safety of supersaturated oxygen (SSO ) infused into the left main coronary after percutaneous coronary intervention for anterior ST-elevation myocardial infarction (STEMI), demonstrated a net adverse clinical event rate of 7.1%, lower than the Food and Drug Administration-set goal of 10.7%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28202DOI Listing
April 2019
4 Reads

An under-recognized high-risk atrial fibrillation population: Analyzing transcatheter mitral valve repair patients for left atrial appendage closure device application.

Catheter Cardiovasc Interv 2019 Apr 5. Epub 2019 Apr 5.

Department of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota.

Objective: Identify patients undergoing transcatheter mitral valve repair (TMVR) who could potentially benefit from alternative ischemic stroke prophylaxis utilizing a left atrial appendage closure (LAAC) device.

Background: Patients undergoing TMVR have a high incidence of atrial fibrillation (AF). The co-morbidities which qualify them to undergo TMVR also increase their risk of stroke and bleeding, making stroke prophylaxis problematic. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28220DOI Listing
April 2019
1 Read

OCT-assessment of scaffold resorption: Analysis of strut intensity by a new resorption index for poly-l-lactic acid bioresorbable vascular scaffolds.

Catheter Cardiovasc Interv 2019 Apr 3. Epub 2019 Apr 3.

Department of Cardiology, Friedrich-Alexander Universität (FAU) Erlangen-Nürnberg, University Hospital Erlangen, Erlangen, Germany.

Background: The aim of this study was to analyze individual differences in resorption of bioresorbable vascular scaffolds (BRS) through optical coherence tomography (OCT) analysis and to identify factors potentially influencing the resorption process.

Methods: Between April 2016 and July 2017 clinically driven invasive coronary angiography and OCT examinations were performed in 36 patients who had previously been treated with a total of 48 BRS (ABSORB BVS, Abbott Vascular, Santa Clara, CA). For each scaffold, a new BRS-RESORB-INDEX (BRI) was calculated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28223DOI Listing
April 2019
1 Read

Highly-calcific carotid lesions endovascular management in symptomatic and increased-stroke-risk asymptomatic patients using the CGuard™ dual-layer carotid stent system: Analysis from the PARADIGM study.

Catheter Cardiovasc Interv 2019 Apr 3. Epub 2019 Apr 3.

Department of Cardiac & Vascular Diseases, John Paul II Hospital, Jagiellonian University Medical College, Krakow, Poland.

Objectives: To assess feasibility, safety, angiographic, and clinical outcome of highly-calcific carotid stenosis (HCCS) endovascular management using CGuard™ dual-layer carotid stents.

Background: HCCS has been a challenge to carotid artery stenting (CAS) using conventional stents. CGuard combines a high-radial-force open-cell frame conformability with MicroNet sealing properties. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28219DOI Listing
April 2019
1 Read

Left internal mammary artery to pulmonary artery fistula causing coronary steal syndrome: A review of literature on therapy, intervention, and management.

Catheter Cardiovasc Interv 2019 Apr 3. Epub 2019 Apr 3.

Department of Cardiology, Staten Island University Hospital, Northwell Health, Staten Island, New York.

Coronary artery anomalies (CAA) are anatomical aberrations in the origin, structure, and course of the epicardial arteries. Literature has detailed common anomalies or fistulas formed because of coronary artery bypass grafting (CABG) manipulation of intrathoracic vessels. Despite the commonality of the CABG procedure, there are a few CAA and fistula findings which remain extremely rare. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28225DOI Listing
April 2019
1 Read
2.107 Impact Factor

Clinical outcomes of percutaneous mitral valve repair with MitraClip for the management of functional mitral regurgitation.

Catheter Cardiovasc Interv 2019 Apr 1. Epub 2019 Apr 1.

School of Medicine, Bahcesehir University, Istanbul, Turkey.

Objectives: To evaluate the safety and efficacy of percutaneous mitral valve repair for the management of functional mitral insufficiency.

Background: Severe FMR is present in 25-30% of patients with heart failure and is an independent predictor of mortality and hospitalizations in patients with both ischemic and nonischemic cardiomyopathy. MitraClip therapy has been approved for high surgical risk patients with primary mitral regurgitation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28203DOI Listing
April 2019
3 Reads

Short- and long-term results with a percutaneous treatment in critical hand ischaemia.

Catheter Cardiovasc Interv 2019 Mar 29. Epub 2019 Mar 29.

Heart and Vascular Center, Semmelweis University, Budapest, Hungary.

Background: The aim of this prospective registry was to determine the feasibility, safety, and outcomes of percutaneous transluminal angioplasty and thrombolysis in the treatment of critical hand ischemia (CHI).

Methods: One-hundred one patients (aged 60.6 ± 15. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28166DOI Listing
March 2019
4 Reads

Transpedal vs. femoral access for peripheral arterial interventions-A single center experience.

Catheter Cardiovasc Interv 2019 Mar 28. Epub 2019 Mar 28.

Department of Medicine, Division of Cardiology, Mount Sinai Beth Israel, New York, New York.

Objective: To compare the transpedal approach to established femoral approach for endovascular treatment of infrainguinal peripheral arterial disease.

Background: Endovascular treatment of infrainguinal peripheral arterial disease is on the rise. Femoral approach is widely used but has significant complications. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28209DOI Listing
March 2019
1 Read

A "minimalistic hybrid algorithm" in coronary chronic total occlusion revascularization: Procedural and clinical outcomes.

Catheter Cardiovasc Interv 2019 Mar 14. Epub 2019 Mar 14.

Department of Cardiology, Sint Antonius Ziekenhuis, Nieuwegein, The Netherlands.

Background: Percutaneous recanalization of coronary chronic total occlusions (CTOs) traditionally relies on the use of dual-access and large bore catheters, with trans-femoral approach adoption in most cases.

Objectives: Aim of this manuscript is to describe the outcomes of an alternative hybrid algorithm, called "Minimalistic Hybrid Algorithm," which has the purpose to minimize the use of double access, large bore catheters, and femoral approach in order to minimize the risk of vascular complications and patient's discomfort, without compromising efficacy.

Methods: In this single-center registry, a "minimalistic" approach was attempted in consecutive patients undergoing CTO PCI between March 2016 and October 2017. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28213DOI Listing

Successful repositioning of apically tethered transcatheter mitral valve replacement in the off-bypass, beating heart.

Catheter Cardiovasc Interv 2019 Mar 27. Epub 2019 Mar 27.

Department of Cardiology, St. Vincent's Hospital, Sydney, Australia.

A 73-year-old man with severe, symptomatic secondary mitral regurgitation (MR) underwent successful transcatheter mitral valve replacement using the Tendyne™ mitral valve system. The device was deployed from the left ventricular (LV) apex and secured in position by a tether attached to an epicardial pad. Three days postoperatively, the patient developed hemolytic anemia and a paravalvular leak (PVL) associated with indentation of the LV apex. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28210DOI Listing
March 2019
1 Read

Is the S.M.A.R.T stent the smart option to treat femoropopliteal disease?

Catheter Cardiovasc Interv 2018 Jul;92(1):115-116

St. Luke's Hospital, University of Arizona College of Medicine, Phoenix, Arizona.

The femoropopliteal (FP) artery is a common site for endovascular interventions. S.M. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27696DOI Listing

Patent foramen ovale closure for cryptogenic stroke: Effective, but only in select patients.

Catheter Cardiovasc Interv 2018 Jul;92(1):174-175

Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, Alabama.

PFO closure reduces risk of recurrent stroke in some patients with cryptogenic stroke, particularly younger patients <45 years with moderate or greater right to left shunting Number needed to treat (NNT) to prevent one stroke at 5 years are 28 to 69 (95% confidence limits of 21 to 351) suggesting need for individualized risk stratification models PFO closure may increase short- and possibly long-term risk of atrial flutter/fibrillation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27700DOI Listing
July 2018
1 Read

Issue Information - Editorial Board.

Authors:

Catheter Cardiovasc Interv 2018 Jul;92(1):iii

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27282DOI Listing
July 2018
1 Read

Who can we save after an intraprocedural catastrophe during TAVR?

Catheter Cardiovasc Interv 2018 Jul;92(1):157-158

Department of Cardiac Surgery, MedStar Washington Hospital Center, Washington, DC.

Intraprocedural catastrophes during transcatheter aortic valve replacement (TAVR) are associated with a high mortality. Even "operable patients" can suddenly be deemed inoperable during an intraprocedural TAVR complication. The low incidence of a major complication prevents "crowd learning"; consequently, a high-volume TAVR center will have the greatest capability for a robust salvage response. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27693DOI Listing
July 2018
1 Read

Hemophilia in the cath lab: Balancing the need to clot with the treatment of thrombosis.

Catheter Cardiovasc Interv 2018 Jul;92(1):16-17

College of Medicine, Heart & Vascular Institute, MS Hershey Medical Center, Pennsylvania State University, Hershey, Pennsylvania.

Hemophilia is a rare genetic disorder that inherently results in bleeding risks that can be successfully managed in the cardiac catheterization laboratory. Standard of care options such as drug-coated stents should not be denied hemophiliacs solely on the basis of their genetic defect. Successful care of hemophilia requires a close collaboration with a specialist in these bleeding disorders to optimize care. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27701DOI Listing
July 2018
2 Reads

Don't worry and measure FFR.

Catheter Cardiovasc Interv 2018 Jul;92(1):28-29

Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

FFR-guided PCI was associated with better clinical outcomes regarding the reduction of myocardial infarction and major adverse cardiac events. The clinical benefit of FFR-guided PCI was achieved with less stents and procedural cost, without additional effects on procedural time and contrast volume. Physicians should measure FFR of target stenosis prior to PCI if there is no objective evidence of myocardial ischemia. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27694DOI Listing

PFO closure: Where are the neurologists?

Catheter Cardiovasc Interv 2018 Jul;92(1):187-188

Heart Institute, Geisinger Health System, Danville, Pennsylvania.

A meta-analysis of five randomized controlled trials of closure of patent foramen ovale (PFO) versus medical therapy to prevent recurrent stroke shows a statistically significant absolute 2% decrease in recurrent stroke but no difference in death. Patients treated with PFO closure have an absolute 2% increase in the risk of atrial fibrillation, usually transient, after the procedure, as well as increased risk of procedural complications, which are usually minor. Guidelines on PFO closure were written before most data in this meta-analysis were available. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27699DOI Listing

Direct physiologic assessment of anomalous aortic origin of a coronary artery: Enhanced diagnostics or illusion of insight?

Catheter Cardiovasc Interv 2018 Jul;92(1):76-77

Stanford University, Palo Alto, California.

Fractional flow reserve and intravascular ultrasound evaluation are technically feasible in patients with congenitally abnormal coronary arteries arising from the wrong aortic sinus, including those with a slitlike orifice and presumed intramural course. Incorporation of fractional flow reserve and intravascular ultrasound into the evaluation of adults with anomalous coronary artery origins will provide additional data and may be useful in risk assessment, although these data should be interpreted with caution, as the validity of fractional flow reserve findings in this population has not been established. The applicability of fractional flow reserve thresholds for acute coronary syndromes to patients with anomalous coronary artery origins is unknown. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27695DOI Listing

SYNTAX II in the "real world" - A practical approach to coronary risk-stratification.

Catheter Cardiovasc Interv 2018 Jul;92(1):48-49

Department of Cardiovascular Diseases, Lahey Hospital and Medical Center, Burlington, Massachusetts.

The SYNTAX II score is valid in the real world, and can be applied to international patient cohorts It is an independent predictor of overall mortality and other cardiovascular endpoints It is a practical tool for coronary risk stratification given its inclusion of pertinent clinical data in addition to anatomic data. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27703DOI Listing
July 2018
1 Read

Issue Information - TOC.

Authors:

Catheter Cardiovasc Interv 2018 Jul;92(1):v-vii

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.27281DOI Listing

Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation.

Catheter Cardiovasc Interv 2019 Mar 27. Epub 2019 Mar 27.

Cardiology Unit, Cardio-Thoracic-Vascular Department, University Hospital of Bologna, Bologna, Italy.

Objectives: To evaluate the long-term impact of coronary artery disease (CAD) and heart team-guided incomplete coronary revascularization in patients undergoing transcatheter aortic valve implantation (TAVI).

Background: Revascularization strategy of CAD diagnosed with routine coronary angiography before TAVI is uncertain.

Methods: Five hundred and forty consecutive TAVI patients were classified as having CAD or normal coronary arteries (no-CAD). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ccd.28211DOI Listing
March 2019
1 Read